GEGottfried Endel

Gottfried Endel

*This is an algorithmically generated author record based on publicly available information.

Gottfried Endel has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Trends in diabetes incidence in Austria 2013–2017

    by Michaela Kaleta, Michael Leutner, Stefan Thurner, Gottfried Endel, Noemi Kiss, Martin Robausch, Peter Klimek, Alexandra Kautzky-Willer

    This study aims to quantify whether age and sex groups in Austrian regions are equally affected by the rise of type 2 diabetes. Population-wide medical claims data was obtained for citizens in Austria aged above 50 year, who received antihyperglycemic treatments or underwent HbA1c monitoring between 2012 and 2017. Diabetes incidence was measured using an epidemiological diabetes progression model accounting for patients who discontinued antihyperglycemic therapy; the erratic group. Out of 746,184 patients, 268,680 (140,960 females) discontinued their treatment and/or monitoring for at least one year. Without adjusting for such erratic patients, incidence rates increase from 2013 to 2017 (females: from 0·5% to 1·1%, males: 0·5% to 1·2%), whereas they decrease in all groups after adjustments (females: − 0·3% to − 0·5%, males: − 0·4% to − 0·5%). Higher mortality was observed in the erratic group compared to patients on continued antihyperglycemic therapy (mean difference 12% and 14% for females and males, respectively). In summary, incidence strongly depends on age, sex and place of residency. One out of three patients with diabetes in Austria discontinued antihyperglycemic treatment or glycemic monitoring for at least one year. This newly identified subgroup raises concern regarding adherence and continuous monitoring of diabetes care and demands further evaluation.


  • Open Access

    Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities—An Agent-Based Modeling Evaluation

    by Beate Jahn, Gaby Sroczynski, Martin Bicher, Claire Rippinger, Nikolai Mühlberger, Júlia Santamaria, Christoph Urach, Michael Schomaker, Igor Stojkov, Daniela Schmid, et al.

    (1) Background: The Austrian supply of COVID-19 vaccine is limited for now. We aim to provide evidence-based guidance to the authorities in order to minimize COVID-19-related hospitalizations and deaths in Austria. (2) Methods: We used a dynamic agent-based population model to compare different vaccination strategies targeted to the elderly (65 ≥ years), middle aged (45–64 years), younger (15–44 years), vulnerable (risk of severe disease due to comorbidities), and healthcare workers (HCW). First, outcomes were optimized for an initially available vaccine batch for 200,000 individuals. Second, stepwise optimization was performed deriving a prioritization sequence for 2.45 million individuals, maximizing the reduction in total hospitalizations and deaths compared to no vaccination. We considered sterilizing and non-sterilizing immunity, assuming a 70% effectiveness. (3) Results: Maximum reduction of hospitalizations and deaths was achieved by starting vaccination with the elderly and vulnerable followed by middle-aged, HCW, and younger individuals. Optimizations for vaccinating 2.45 million individuals yielded the same prioritization and avoided approximately one third of deaths and hospitalizations. Starting vaccination with HCW leads to slightly smaller reductions but maximizes occupational safety. (4) Conclusion: To minimize COVID-19-related hospitalizations and deaths, our study shows that elderly and vulnerable persons should be prioritized for vaccination until further vaccines are available.


  • Open Access

    Algorithms to identify COPD in health systems with and without access to ICD coding: a systematic review

    by Holger Gothe, Sasa Rajsic, Djurdja Vukicevic, Tonio Schoenfelder, Beate Jahn, Sabine Geiger-Gritsch, Diana Brixner, Niki Popper, Gottfried Endel, Uwe Siebert

    Background: Chronic obstructive pulmonary disease (COPD) causes significant morbidity and mortality worldwide. Estimation of incidence, prevalence and disease burden through routine insurance data is challenging because of under-diagnosis and under-treatment, particularly for early stage disease in health care systems where outpatient International Classification of Diseases (ICD) diagnoses are not collected. This poses the question of which criteria are commonly applied to identify COPD patients in claims datasets in the absence of ICD diagnoses, and which information can be used as a substitute. The aim of this systematic review is to summarize previously reported methodological approaches for the identification of COPD patients through routine data and to compile potential criteria for the identification of COPD patients if ICD codes are not available.Methods: A systematic literature review was performed in Medline via PubMed and Google Scholar from January 2000 through October 2018, followed by a manual review of the included studies by at least two independent raters. Study characteristics and all identifying criteria used in the studies were systematically extracted from the publications, categorized, and compiled in evidence tables.Results: In total, the systematic search yielded 151 publications. After title and abstract screening, 38 publications were included into the systematic assessment. In these studies, the most frequently used (22/38) criteria set to identify COPD patients included ICD codes, hospitalization, and ambulatory visits. Only four out of 38 studies used methods other than ICD coding. In a significant proportion of studies, the age range of the target population (33/38) and hospitalization (30/38) were provided. Ambulatory data were included in 24, physician claims in 22, and pharmaceutical data in 18 studies. Only five studies used spirometry, two used surgery and one used oxygen therapy.Conclusions: A variety of different criteria is used for the identification of COPD from routine data. The most promising criteria set in data environments where ambulatory diagnosis codes are lacking is the consideration of additional illness-related information with special attention to pharmacotherapy data. Further health services research should focus on the application of more systematic internal and/or external validation approaches.


  • Open Access

    Patient-Sharing Relations in the Treatment of Diabetes and Their Implications for Health Information Exchange: Claims-Based Analysis

    by Georg Duftschmid, Christoph Rinner, Simone Katja Sauter, Gottfried Endel, Peter Klimek, Christoph Mitsch, Harald Heinzl

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Health information exchange (HIE) between care providers who cooperate in the treatment of patients with diabetes mellitus (DM) has been rated as an important aspect of successful care. Patient-sharing relations between care providers permit inferences about corresponding information-sharing relations. Objective: By analyzing patient-sharing relations between various types of care providers (ToCPs) - such as hospitals, pharmacies and different outpatient specialists - within a nationwide claims dataset of Austrian DM patients, we aimed to obtain information for an effective design of HIE platforms to be used in DM care. We focus on two parameters derived from patient-sharing networks: (i) the principal HIE partners of the different ToCPs involved in the treatment of DM, and (ii) the required participation rate of ToCPs in HIE platforms for the purpose of effective communication. Methods: Claims data of 7.9 million Austrian patients from 2006 and 2007 served as our data source. DM patients were identified by their medication. We established metrics for the quantification of our two parameters of interest. The principal HIE partners are derived from the portions of a care provider’s patient-sharing relations with different ToCPs. For the required participation rate of ToCPs in an HIE platform, we determine the concentration of patient-sharing relations between ToCPs. Our corresponding metrics are derived in analogy from existing work for the quantification of the continuity of care. Results: We identified 324,703 DM patients treated by 12,226 care providers; the latter were members of 16 ToCPs. Based on their score for our two parameters, we categorized the ToCPs into “low”, “medium”, and “high”. For the parameter named “most important HIE partner”, pharmacies, general practitioners (GPs), and laboratories were the representatives of the top group, i.e. our care providers shared the highest numbers of DM patients with these ToCPs. Concerning the parameter “required participation rate of ToCP in HIE platform”, the concentration of DM patient-sharing relations with a ToCP tended to be inversely related to the ToCP’s member count. Conclusions: We conclude that GPs, pharmacies, and laboratories should be core members of any HIE platform that supports DM care, as they are the most important DM patient-sharing partners. We further conclude that, for implementing HIE with ToCPs that have many members (in Austria particularly GPs and pharmacies), an HIE solution with high participation rates of these ToCPs (ideally a nationwide HIE platform with obligatory participation of the concerned ToCPs) seems essential. This will raise the probability of HIE being achieved with any care provider of these ToCPs. As chronic diseases are rising due to aging societies, we believe that our quantification of HIE requirements in the treatment of DM can provide valuable insights for many industrial countries.


  • Open Access

    Patient-Sharing Relations in the Treatment of Diabetes and Their Implications for Health Information Exchange: Claims-Based Analysis (Preprint)

    by Georg Duftschmid, Christoph Rinner, Simone Katja Sauter, Gottfried Endel, Peter Klimek, Christoph Mitsch, Harald Heinzl

    BACKGROUND Health information exchange (HIE) among care providers who cooperate in the treatment of patients with diabetes mellitus (DM) has been rated as an important aspect of successful care. Patient-sharing relations among care providers permit inferences about corresponding information-sharing relations. OBJECTIVES This study aimed to obtain information for an effective HIE platform design to be used in DM care by analyzing patient-sharing relations among various types of care providers (ToCPs), such as hospitals, pharmacies, and different outpatient specialists, within a nationwide claims dataset of Austrian DM patients. We focus on 2 parameters derived from patient-sharing networks: (1) the principal HIE partners of the different ToCPs involved in the treatment of DM and (2) the required participation rate of ToCPs in HIE platforms for the purpose of effective communication. METHODS The claims data of 7.9 million Austrian patients from 2006 to 2007 served as our data source. DM patients were identified by their medication. We established metrics for the quantification of our 2 parameters of interest. The principal HIE partners were derived from the portions of a care provider’s patient-sharing relations with different ToCPs. For the required participation rate of ToCPs in an HIE platform, we determine the concentration of patient-sharing relations among ToCPs. Our corresponding metrics are derived in analogy from existing work for the quantification of the continuity of care. RESULTS We identified 324,703 DM patients treated by 12,226 care providers; the latter were members of 16 ToCPs. On the basis of their score for 2 of our parameters, we categorized the ToCPs into low, medium, and high. For the most important HIE partner parameter, pharmacies, general practitioners (GPs), and laboratories were the representatives of the top group, that is, our care providers shared the highest numbers of DM patients with these ToCPs. For the required participation rate of type of care provide (ToCP) in HIE platform parameter, the concentration of DM patient-sharing relations with a ToCP tended to be inversely related to the ToCPs member count. CONCLUSIONS We conclude that GPs, pharmacies, and laboratories should be core members of any HIE platform that supports DM care, as they are the most important DM patient-sharing partners. We further conclude that, for implementing HIE with ToCPs who have many members (in Austria, particularly GPs and pharmacies), an HIE solution with high participation rates from these ToCPs (ideally a nationwide HIE platform with obligatory participation of the concerned ToCPs) seems essential. This will raise the probability of HIE being achieved with any care provider of these ToCPs. As chronic diseases are rising because of aging societies, we believe that our quantification of HIE requirements in the treatment of DM can provide valuable insights for many industrial countries.

  • Open Access

    Mortality and continuity of care – Definitions matter! A cohort study in diabetics

    by Angelika Geroldinger, Simone Katja Sauter, Georg Heinze, Gottfried Endel, Wolfgang Dorda, Georg Duftschmid

    To demonstrate that when investigating the relevance of continuity of care for patient outcomes, different definitions can lead to contradicting results. We used claims data from the regional public health insurer of Lower Austria covering the period from 2008 to 2011. The study sample included subjects with repeated dispensings of anti-diabetic drugs. The continuity of care index was calculated firstly based on a patient’s contacts with general practitioners (primary COCI) and secondly based on contacts at all medical disciplines (total COCI). The association of the two continuity of care measures with mortality was assessed in separate univariable and multivariable Cox regression models. Our study sample consisted of 51,717 patients with a median observation time of 3.65 years. The data showed that a high total COCI was associated with increased mortality, while there was no association between primary COCI and mortality. Measures of continuity of care are highly sensitive to the type of medical disciplines taken into account. The continuity of care index calculated from contacts at all medical disciplines might measure diversity rather than continuity of care.


  • Open Access

    Improving the informational continuity of care in diabetes mellitus treatment with a nationwide Shared EHR system: Estimates from Austrian claims data

    by Christoph Rinner, Simone Katja Sauter, Gottfried Endel, Georg Heinze, Stefan Thurner, Peter Klimek, Georg Duftschmid


    • 1 January 2012
      • Vol. 180, 667-71

    Fragmentation of diabetes treatment in Austria - an indicator for the need for shared electronic health record systems.

    by Georg Duftschmid, Wolfgang Dorda, Gottfried Endel, Karl Fröschl, Walter Gall, Wilfried Grossmann, Milan Hronsky

    Shared electronic health record (EHR) systems aim to support continuity of care within the joint treatment of a patient by a community of cooperating care providers. By analyzing the fragmentation of care of Austrian diabetes patients, we aim to find evidence whether there is actually a need for shared EHR systems in this context. Our results show that almost three quarters of the observed diabetes patients visit two or more different care providers during their diabetes-related visits. Overall, our findings strongly support the demand for shared EHR systems for the treatment of diabetes patients.